Navigation Links
Cerecor Acquires Rights to NR2B Receptor Antagonist from Merck
Date:4/19/2013

BALTIMORE, April 19, 2013 /PRNewswire/ -- Cerecor Inc, a neuroscience biotech company that develops therapies that have the potential to make a difference in diseases with high unmet medical needs, today announced that it has acquired exclusive, worldwide rights from Merck, known as MSD outside the United States and Canada, to develop and commercialize MK-0657, a small molecule NMDA receptor subunit 2B (NR2B) antagonist for all human indications, including depression.

There is a growing body of evidence to support the hypothesis that NMDA receptors are involved in the pathology of depression, including reports in the literature of rapid improvement of depression following intravenous administration of ketamine, an NMDA antagonist. MK-0657 is a novel potent and selective NR2B antagonist, initially developed by Merck for the treatment of Parkinson's disease.

"MK-0657 is a potential first-in-class, best-in-class, oral medication that is complementary to existing treatments in depressed patients who have failed to respond to available therapies. We are particularly interested in the potential to rapidly reduce depressive symptoms, including suicidal ideation, in these severely affected patients," stated Dr. James Vornov , Cerecor's Sr. VP of Clinical Development and Regulatory Affairs.

Under the terms of the agreement, Cerecor will immediately assume full development and commercialization responsibilities of MK-0657.  License consideration includes milestone payments and royalties consistent with clinical stage licenses in neuroscience. Cerecor anticipates completing the technology transfer activities by mid-2013 and thereafter initiating clinical trials.

"We are delighted that Merck has chosen Cerecor to help realize the value of an innovative asset such as MK-0657," added Dr. Blake Paterson ,
'/>"/>

SOURCE Cerecor Inc
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Cerecor Acquires Rights to Merck COMT Inhibitors
2. Cerecor Announces Option to Johns Hopkins Brain Science Institute DAAO Inhibitor Platform
3. Dr. Magnus Persson Joins Cerecors Board of Directors
4. Cerecor Announces Initiation of CLIN01-002-A
5. MD Anderson Cancer Center Acquires Two Elekta Versa HD Systems
6. Numotion Acquires Ultimate Mobility, Inc.
7. VWR International, LLC Acquires Basan UK Limited
8. Kimberly-Clark Health Care Acquires Anesthesia Business from Life-Tech
9. VWR International, LLC Acquires Prolab Laboratuar Teknolojileri Limited In Turkey
10. Oncologix Tech Inc. (OCLG) Acquires Dotolo; Gains Ongoing Sales, Patents, and New CEO
11. Kimberly-Clark Heath Care Acquires Anesthesia Business from Life-Tech
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/28/2015)... , May 28, 2015 Another ... hospital of the future. In connection with extensive modernization ... de Majorca is equipping its clinic with ... decided to install the innovative ClinicAll System, thereby achieving ... standard infotainment services for patients, ClinicAll also offers significant ...
(Date:5/28/2015)... , May 28, 2015 ... the concerned market with analysis and forecast of revenue. ... and is estimated to reach $1,177.8 million by 2019, ... Browse through the TOC of Mannequin-Based Simulation ... and segments, with help of various tables and figures. ...
(Date:5/28/2015)... , May 28, 2015  Array BioPharma Inc. ... binimetinib and selumetinib (licensed to AstraZeneca) at the 2015 ... will be held May 29 – June 2, 2015 ... products are currently advancing in a total of 6 ... both the NEMO (binimetinib monotherapy in NRAS mutant melanoma ...
Breaking Medicine Technology:Groundbreaking Step Towards a Cost-efficient Future 2Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 2Mannequin-Based Simulation Market Report is Expected to Reach $1,177.8 Million by 2019, at a CAGR of 19.4% from 2014 to 2019 3Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 2Array BioPharma Announces Clinical Data Presentations At The 2015 ASCO Annual Meeting 3
... -- 3SBio Inc. (NASDAQ: SSRX ) ("3SBio" ... on researching, developing, manufacturing and marketing biopharmaceutical products, today ... and first half ended June 30, 2011. ... Total net revenues increased by 29.0% over the second ...
... JOSEPH, Mo., Aug. 15, 2011 On Sunday, August ... Boston. Veterinary cardiologists on the Mobile Dog Heart Health ... perform free dog heart examinations at Peters Park Dog ... In addition to providing free heart health screenings, veterinarians ...
Cached Medicine Technology:3SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 23SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 33SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 43SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 53SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 63SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 73SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 83SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 93SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 103SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 113SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 123SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 133SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 143SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 153SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 163SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 173SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 183SBio Inc. Announces Unaudited Second Quarter and First Half 2011 Results 19Free Dog Heart Health Screenings Available August 21 in Boston 2
(Date:5/28/2015)... Workers’ compensation costs per claim in Michigan were lower ... the Workers Compensation Research Institute (WCRI) said, with ... WCRI study, CompScope™ Benchmarks for Michigan, 15th Edition, ... more of work with those of 16 other states. ... 4 percent lower than similar claims from 2008. That was ...
(Date:5/28/2015)... May 28, 2015 Baptist Medical Center ... patients suffering from acute stroke or other neurological conditions. ... one of a few in the country and the ... emergency needs such as brain aneurysms. , “Baptist ... care of patients who are impacted by stroke,” said ...
(Date:5/28/2015)... Houston, TX (PRWEB) May 28, 2015 ... respected cosmetic surgeons , has announced that the new ... Accreditation. The American Association of Accreditation of Ambulatory Surgery ... state-of-the-art surgery center . , According to Dr. ... for meeting the standards of a Class C ambulatory ...
(Date:5/28/2015)... Sexual Health Innovations, a nonprofit ... health and wellbeing in the United States, announced ... (USF) will be the first institution to adopt ... reporting system. , Callisto is designed to ... experience for college sexual assault survivors, to give ...
(Date:5/28/2015)... (PRWEB) May 28, 2015 A bucket ... adventures. Each item on the bucket list ... events, experiences and tasks that the owner wants to ... right or wrong when it comes to making this ... business, writing poems, publishing a book, seeing the Grand ...
Breaking Medicine News(10 mins):Health News:Michigan Workers’ Compensation Costs Lower Than Most States, Says WCRI Study 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 2Health News:Baptist Medical Center Jacksonville Adds Dedicated Neuro Emergency Unit 3Health News:Dr. Paul Vitenas’ New Houston Surgery Center Receives AAAASF Accreditation 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 2Health News:University of San Francisco Becomes First in the Nation to Adopt College Sexual Assault Reporting System 3
... of expertise and other factors when ... ... CIGNA Behavioral Health,(CBH) members can now view robust, online ... including license,levels, languages spoken, educational background, areas of specialization,and years ...
... -- Researchers at Mayo Clinic in Jacksonville have discovered how ... proteins in the brain, resulting in a common dementia, ... number of age-related neurological disorders. , In the Sept. ... that absence of a gene known as progranulin leads to ...
... be on,display throughout The Kroger Co.,s (NYSE: KR ... partners with vendors and suppliers to support,National Breast Cancer ... tags can be found on shelves in Kroger,stores across ... support breast cancer awareness in their community. Several of,Kroger,s ...
... Climb to Conquer Cancer will follow four professional U.S., ... Alaska, NEW YORK, Sept. 27 Fred Hutchinson ... expedition to an unclimbed,mountain in the name of cancer ... expedition. The inaugural Climb to Conquer Cancer, performed ...
... QMed, Inc.,(Nasdaq: QMED ) today announced it ... August 31, 2007 revenue of approximately $10.8 million and,$26.6 ... $13 million,respectively. The Company,s cash position as of August ... Jane Murray, president and CEO, said, "During the ...
... Edition Strawberry Jelly Krimpets Will Benefit Online ... for Breast Cancer Support and Information, PHILADELPHIA, Sept. ... philanthropic product offering, the,Tastykake Strawberry Jelly Krimpet. 10% of ... will be donated to breastcancer.org, a,Narberth, Pennsylvania based online ...
Cached Medicine News:Health News:CIGNA Behavioral Health Offers Members Online Provider Profiles 2Health News:Loss of gene leads to protein splicing and buildup of toxic proteins in neurons 2Health News:Kroger 'Pink Tag' Campaign to Raise $2.5 Million for Breast Cancer Awareness in October 2Health News:Fred Hutchinson Cancer Research Center Announces the First-Ever Expedition to an Unclimbed Mountain in the Name of Cancer Research 2Health News:QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million 2Health News:QMed, Inc. Comments on Estimated 3rd Quarter Results & Medical Expense Ratio; Sets 2008 Revenue Guidance for Medicare SNPs at $88-95 Million 3Health News:Tasty Baking Company Launches New Krimpet to Support Breast Cancer Awareness Through a Partnership with Breastcancer.Org 2Health News:Tasty Baking Company Launches New Krimpet to Support Breast Cancer Awareness Through a Partnership with Breastcancer.Org 3
Inquire...
Inquire...
Inquire...
... operation and optical performance, the SZX7 is ... comfort in every task, from routine preparations ... of the best zoom ratios in its ... true color and accurate reproduction of the ...
Medicine Products: